Long-term follow-up of at least five years after recombinant human thyrotropin compared to levothyroxine withdrawal for thyroid remnant ablation with radioactive iodine.
Pedro Weslley
PW
Rosario
Augusto Flávio Campos
AF
Mineiro Filho
Rafaela Xavier
RX
Lacerda
Maria Regina
MR
Calsolari
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D013965:Thyroidectomy; D057073:Thyrotropin Alfa / Q000008:administration & dosage*; D013974:Thyroxine / Q000008:administration & dosage*
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D057073:Thyrotropin Alfa; D013974:Thyroxine